1919 Investment Counsel’s Elevance Health ELV Stock Holding History

1919 Investment Counsel’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$899K	Sell	7,510 -435	-5%	-$49.9K	0.02%	395
2014 Q2	$855K	Sell	7,945 -100	-1%	-$10.3K	0.02%	407
2014 Q1	$801K	Sell	8,045 -1,520	-16%	-$137K	0.02%	399
2013 Q4	$884K	Buy	9,565 +2,050	+27%	+$182K	0.02%	391
2013 Q3	$629K	Buy	7,515 +5,765	+329%	+$494K	0.01%	412
2013 Q2	$144K	Buy	+1,750	New	+$131K	﹤0.01%	539

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

1919 Investment Counsel's ELV Position: Q3 2014 in Review

1919 Investment Counsel reduced its Elevance Health (ELV) stake by 5.5% in Q3 2014, selling an estimated $49.9K and leaving 7,510 shares worth $899K. The position accounts for 0.02% of the portfolio, ranked #395.

1919 Investment Counsel first reported a position in ELV in Q2 2013 and has held it in 6 quarters since. 707 funds tracked by Wall St. Rank hold ELV as of Q3 2014.

1919 Investment Counsel held 7,510 shares of Elevance Health worth $899K as of Q3 2014.
1919 Investment Counsel sold 435 Elevance Health shares in Q3 2014, an estimated $49.9K.
Elevance Health made up 0.02% of 1919 Investment Counsel's portfolio in Q3 2014, its #395 holding.
1919 Investment Counsel first reported a position in Elevance Health in Q2 2013 and has held it in 6 quarters since.
707 funds tracked by Wall St. Rank held Elevance Health as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.